> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Morton Grove Closes Business Over GMP Violations
- URL: https://www.fdaweb.com/morton-grove-closes-business-over-gmp-violations/
- Published: 2022-08-23T12:00:00.000Z
- Updated: 2026-09-14T17:57:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5152567

The Northern District of Illinois federal court has approved a [consent decree](https://www.justice.gov/opa/press-release/file/1527456/download?ref=fdaweb.com) of permanent injunction that orders Morton Grove Pharmaceuticals to stop making and distributing drugs alleged to be adulterated in violation of the Federal Food, Drug, and Cosmetic Act (FDCA). Under the decree, the firm decided for commercial reasons to close its business and sell the site. Further, it must destroy all drugs at the facility except those identified as medically necessary.

Morton Grove was making prescription and over-the-counter drugs, such as cough syrups and nasal sprays at the time of the decree. The government contends that the company violated the FDCA by “failing to have adequate procedures to prevent cross-contamination of equipment, failing to reject drug lots using a contaminated ingredient, and failing to fully investigate the root cause of such contamination,” according to a Justice Department [release](https://www.justice.gov/opa/pr/district-court-enjoins-illinois-pharmaceutical-manufacturer-making-and-selling-adulterated?ref=fdaweb.com). It cites inspections in 2011, 2014, 2016, 2019 and 2021, noting that many violations were repeat findings identified in earlier inspections.